Abstract
Studies have shown interventions that reduce total and low-density lipoprotein cholesterol levels also decrease subsequent coronary heart disease (CHD) and stroke events in those with a history of CHD. However, it is uncertain whether pharmacological alteration of lipid levels in those with a history of cerebrovascular disease can prevent recurrence of either stroke or subsequent cardiovascular events.
Original language | English |
---|---|
Pages (from-to) | e622-e623 |
Number of pages | 2 |
Journal | Stroke |
Volume | 40 |
Issue number | 11 |
DOIs | |
Publication status | Published - 2009 |